why choose us

First received: March 28, 2024

Clinical Trial: A Study of LY3841136 in Overweight and Obese Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Multiple Dose Combination Study to Evaluate the Safety and Tolerability of Tirzepatide and LY3841136 in Overweight and Obese Participants

Brief Summary: The main purpose of this study is to assess the safety and tolerability of LY3841136 when administered in combination with tirzepatide in overweight and obese patients.The study will last up to approximately 42 weeks.

Read more